References
- Akiyama, K., Ohga, N., Hida, Y., Kawamoto, T., Sadamoto, Y., Ishikawa, S., Maishi, N., Akino, T., Kondoh, M., Matsuda, A., et al. (2012). Tumor endothelial cells acquire drug resistance by MDR1 up-regulation via VEGF signaling in tumor microenvironment. Am. J. Pathol. 180, 1283-1293. https://doi.org/10.1016/j.ajpath.2011.11.029
- Bonet, C., Giuliano, S., Ohanna, M., Bille, K., Allegra, M., Lacour, J.P., Bahadoran, P., Rocchi, S., Ballotti, R., and Bertolotto, C. (2012). Aurora B is regulated by the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway and is a valuable potential target in melanoma cells. J. Biol. Chem. 287, 29887-29898. https://doi.org/10.1074/jbc.M112.371682
- Chae, S., Kim, Y.B., Lee, J.S., and Cho, H. (2012). Resistance to paclitaxel in hepatoma cells is related to static JNK activation and prohibition into entry of mitosis. Am. J. Physiol. Gastrointest. Liver Physiol. 302, 1016-1024. https://doi.org/10.1152/ajpgi.00449.2011
- Chen, L.F., Fischle, W., Verdin, E., and Greene, W.C. (2001). Duration of nuclear NF-kappaB action regulated by reversible acetylation. Science 293, 1653-1657. https://doi.org/10.1126/science.1062374
- Cittelly, D.M., Dimitrova, I., Howe, E.N., Cochrane, D.R., Jean, A., Spoelstra, N.S., Post, M.D., Lu, X., Broaddus, R.R., Spillman, M.A., et al. (2012). Restoration of miR-200c to ovarian cancer reduces tumor burden and increases sensitivity to paclitaxel. Mol. Cancer Ther. 11, 2556-2565. https://doi.org/10.1158/1535-7163.MCT-12-0463
- Du, L., Subauste, M.C., DeSevo, C., Zhao, Z., Baker, M., Borkowski, R., Schageman, J.J., Greer, R., Yang, C.R., Suraokar, M., et al. (2012). miR-337-3p and its targets STAT3 and RAP1A modulate taxane sensitivity in non-small cell lung cancers. PLoS One 7, e39167. https://doi.org/10.1371/journal.pone.0039167
- Fadri-Moskwik, M., Weiderhold, K.N., Deeraksa, A., Chuang, C., Pan, J., Lin, S.H., and Yu-Lee, L.Y. (2012). Aurora B is regulated by acetylation/deacetylation during mitosis in prostate cancer cells. FASEB J. 26, 4057-4067. https://doi.org/10.1096/fj.12-206656
- Fujita, Y., Kojima, K., Ohhashi, R., Hamada, N., Nozawa, Y., Kitamoto, A., Sato, A., Kondo, S., Kojima, T., Deguchi, T., et al. (2010). MiR-148a attenuates paclitaxel resistance of hormonerefractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J. Biol. Chem. 285, 19076-19084. https://doi.org/10.1074/jbc.M109.079525
- Gao, Y.S., Hubbert, C.C., and Yao, T.P. (2010). The microtubuleassociated histone deacetylase 6 (HDAC6) regulates epidermal growth factor receptor (EGFR) endocytic trafficking and degradation. J. Biol. Chem. 285, 11219-11226. https://doi.org/10.1074/jbc.M109.042754
- Hei, C., Cheung, A., Wu, S.Y., Lee, T.R., Chang, C.Y., Wu, J.S., Hsieh, H.P., and Chang, J.Y. (2010). Cancer cells acquire mitotic drug resistance properties through beta I-tubulin mutations and alterations in the expression of beta-tubulin isotypes. PLoS One 5, e12564. https://doi.org/10.1371/journal.pone.0012564
- Hubbert, C., Guardiola, A., Shao, R., Kawaguchi, Y., Ito, A., Nixon, A., Yoshida, M., Wang, X.F., and Yao, T.P. (2002). HDAC6 is a microtubule-associated deacetylase. Nature 417, 455-458. https://doi.org/10.1038/417455a
- Ishii, S., Kurasawa, Y., Wong, J., and Yu-Lee, L.Y. (2008). Histone deacetylase 3 localizes to the mitotic spindle and is required for kinetochore-microtubule attachment. Proc. Natl. Acad. Sci. USA 105, 4179-4184. https://doi.org/10.1073/pnas.0710140105
- Kaluza, D., Kroll, J., Gesierich, S., Yao, T.P., Boon, R.A., Hergenreider, E., Tjwa, M., Rössig, L., Seto, E., Augustin, H.G., et al. (2011). Class IIb HDAC6 regulates endothelial cell migration and angiogenesis by deacetylation of cortactin. EMBO J. 30, 4142-4156. https://doi.org/10.1038/emboj.2011.298
- Kamath, K., Wilson, L., Cabral, F., and Jordan, M.A. (2005). BetaIIItubulin induces paclitaxel resistance in association with reduced effects on microtubule dynamic instability. J. Biol. Chem. 280, 12902-12907. https://doi.org/10.1074/jbc.M414477200
- Kavallaris, M., Kuo, D.Y., Burkhart, C.A., Regl, D.L., Norris, M.D., Haber, M., and Horwitz, S.B. (1997). Taxol-resistant epithelial ovarian tumors are associated with altered expression of specific beta-tubulin isotypes. J. Clin. Invest. 100, 1282-1293. https://doi.org/10.1172/JCI119642
- Kim, H.C., Choi, K.C., Choi, H.K., Kang, H.B., Kim, M.J., Lee, Y.H., Lee, O.H., Lee, J., Kim, Y.J., Jun, W., et al. (2010a). HDAC3 selectively represses CREB3-mediated transcription and migration of metastatic breast cancer cells. Cell. Mol. Life Sci. 67, 3499-3510. https://doi.org/10.1007/s00018-010-0388-5
- Kim, Y., Park, H., Park, D., Lee, Y.S., Choe, J., Hahn, J.H., Lee, H., Kim, Y.M., and Jeoung, D. (2010b). Cancer/testis antigen CAGE exerts negative regulation on p53 expression through HDAC2 and confers resistance to anti-cancer drugs. J. Biol. Chem. 285, 25957-25968. https://doi.org/10.1074/jbc.M109.095950
- Levallet, G., Bergot, E., Antoine, M., Creveuil, C., Santos, A.O., Beau-Faller, M., de Fraipont, F., Brambilla, E., Levallet, J., Morin, F., et al. (2012). High TUBB3 expression, an independent prognostic marker in patients with early non-small cell lung cancer treated by preoperative chemotherapy, is regulated by K-Ras signaling pathway. Mol. Cancer Ther. 11, 1203-1213. https://doi.org/10.1158/1535-7163.MCT-11-0899
- Li, J., Wang, J., Wang, J., Nawaz, Z., Liu, J.M., Qin, J., and Wong, J. (2000). Both corepressor proteins SMRT and N-CoR exist in large protein complexes containing HDAC3. EMBO J. 19, 4342-4350. https://doi.org/10.1093/emboj/19.16.4342
- Lv, K., Liu, L., Wang, L., Yu, J., Liu, X., Cheng, Y., Dong, M., Teng, R., Wu, L., Fu, P., et al. (2012). Lin28 mediates paclitaxel resistance by modulating p21, Rb and Let-7a miRNA in breast cancer cells. PLoS One 7, e40008. https://doi.org/10.1371/journal.pone.0040008
- Mahlknecht, U., Emiliani, S., Najfeld, V., Young, S, and Verdin, E. (1999). Genomic organization and chromosomal localization of the human histone deacetylase 3 gene. Genomics 56. 197-202. https://doi.org/10.1006/geno.1998.5645
- Mahlknecht, U., Will, J., Varin, A., Hoelzer, D., and Herbein, G. (2004). Histone deacetylase 3, a class I histone deacetylase, suppresses MAPK11-mediated activating transcription factor-2 activation and represses TNF gene expression. J. Immunol. 173, 3979-3990. https://doi.org/10.4049/jimmunol.173.6.3979
- Mechetner, E., Kyshtoobayeva, A., Zonis, S., Kim, H., Stroup, R., Garcia, R., Parker, R.J., and Fruehauf, J.P. (1998) Levels of multidrug resistance (MDR1) P-glycoprotein expression by human breast cancer correlate with in vitro resistance to taxol and doxorubicin. Clin. Cancer Res. 4, 389-398.
- Namdar, M., Perez, G., Ngo, L., Paul, A., and Marks, P.A. (2010). Selective inhibition of histone deacetylase 6 (HDAC6) induces DNA damage and sensitizes transformed cells to anticancer agents. Proc. Natl. Acad. Sci. USA 107, 20003-20008. https://doi.org/10.1073/pnas.1013754107
- Ott, P.A., Chang, J., Madden, K., Kannan, R., Muren, C., Escano, C., Cheng, X., Shao, Y., Mendoza, S., Gandhi, A., et al. (2013). Oblimersen in combination with temozolomide and albuminbound paclitaxel in patients with advanced melanoma: a phase I trial. Cancer Chemother. Pharmacol. 71, 183-191. https://doi.org/10.1007/s00280-012-1995-7
- Owonikoko, T.K., Ramalingam, S.S., Kanterewicz, B., Balius, T., Belani, C.P., and Hershberger, P.A. (2010). Vorinostat increases carboplatin and paclitaxel activity in non-small cell lung cancer cells. Int. J. Cancer 126, 743-755. https://doi.org/10.1002/ijc.24759
- Patel, N., Chatterjee, S.K., Vrbanac, V., Chung, I., Mu, C.J., Olsen, R.R., Waghorne, C., and Zetter, B.R. (2010). Rescue of paclitaxel sensitivity by repression of Prohibitin1 in drug-resistant cancer cells Proc. Natl. Acad. Sci. USA 107, 2503-2508. https://doi.org/10.1073/pnas.0910649107
- Seve, P., Reiman, T., and Dumontet, C. (2010). The role of betaIII tubulin in predicting chemoresistance in non-small cell lung cancer. Lung Cancer 67, 136-143. https://doi.org/10.1016/j.lungcan.2009.09.007
- Takakura, Y., Hinoi, T., Oue, N., Sasada, T., Kawaguchi, Y., Okajima, M., Akyol, A., Fearon, E.R., Yasui, W., and Ohdan, H. (2010). CDX2 regulates Multidrug Resistance 1 gene expression in malignant intestinal epithelium. Cancer Res. 70, 6767-6778. https://doi.org/10.1158/0008-5472.CAN-09-4701
- Verdier-Pinard, P., Wang, F., Martello, L., Burd, B., Orr, G.A., and Horwitz, S.B. (2003). Analysis of tubulin isotypes and mutations from taxol-resistant cells by combined isoelectrofocusing and mass spectrometry. Biochemistry 42, 5349-5357. https://doi.org/10.1021/bi027293o
- Wang, L., Xiang, S., Williams, K.A., Dong, H., Bai, W., Nicosia, S.V., Khochbin, S., Bepler, G., and Zhang, X. (2012). Depletion of HDAC6 enhances cisplatin-induced DNA damage and apoptosis in non-small cell lung cancer cells. PLoS One 7, e44265. https://doi.org/10.1371/journal.pone.0044265
- Xie, H., Lee, M.H., Zhu, F., Reddy, K., Peng, C., Li, Y., Lim do, Y., Kim, D.J., Li, X., Kang, S., et al. (2013). Identification of an Aurora kinase inhibitor specific for the Aurora B isoform. Cancer Res. 73, 716-724. https://doi.org/10.1158/0008-5472.CAN-12-2784
- Xu, R., Sato, N., Yanai, K., Akiyoshi, T., Nagai, S., Wada, J., Koga, K., Mibu, R., Nakamura, M., and Katano, M. (2009). Enhancement of paclitaxel-induced apoptosis by inhibition of mitogenactivated protein kinase pathway in colon cancer cells. Anticancer Res. 29, 261-270.
- Xu, R., Nakano, K., Iwasaki, H., Kumagai, M., Wakabayashi, R., Yamasaki, A., Suzuki, H., Mibu, R., Onishi, H., and Katano, M. (2011). Dual blockade of phosphatidylinositol 3'-kinase and mitogen-activated protein kinase pathways overcomes paclitaxelresistance in colorectal cancer. Cancer Lett. 306, 151-160. https://doi.org/10.1016/j.canlet.2011.02.042
- Yan, L.H., Wang, X.T., Yang, J., Lian, C., Kong, F.B., Wei, W.Y., Luo, W., Xiao, Q., and Xie, Y.B. (2013). Reversal of multidrug resistance in gastric cancer cells by CDX2 downregulation. World J. Gastroenterol. 19, 4155-4165. https://doi.org/10.3748/wjg.v19.i26.4155
- Yao, Y.L., Yang, W.M., and Seto, E. (2001). Regulation of transcription factor YY1 by acetylation and deacetylation. Mol. Cell Biol. 21, 5979-5991. https://doi.org/10.1128/MCB.21.17.5979-5991.2001
- Yin, S., Bhattacharya, R., and Cabral, F. (2010). Human mutations that confer paclitaxel resistance. Mol. Cancer Ther. 9, 327. https://doi.org/10.1158/1535-7163.MCT-09-0674
- Zhang, J., Kalkum, M., Chait, B.T., and Roeder, R.G. (2002). The N-CoR-HDAC3 nuclear receptor corepressor complex inhibits the JNK pathway through the integral subunit GPS2. Mol. Cell 9, 611-623. https://doi.org/10.1016/S1097-2765(02)00468-9
- Zhang, Y., Li, N., Caron, C., Matthias, G., Hess, D., Khochbin, S., and Matthias, P. (2003). HDAC-6 interacts with and deacetylates tubulin and microtubules in vivo. EMBO J 22, 1168-1179. https://doi.org/10.1093/emboj/cdg115
- Zhang, X., Ozawa, Y., Lee, H., Wen, Y.D., Tan,T.H., Wadzinski, B.E., and Seto, E. (2005). Histone deacetylase 3 (HDAC3) activity is regulated by interaction with protein serine/threonine phosphatase 4. Genes Dev. 19, 827-839. https://doi.org/10.1101/gad.1286005
Cited by
- Roles of tumor heterogeneity in the development of drug resistance: A call for precision therapy vol.42, 2017, https://doi.org/10.1016/j.semcancer.2016.11.006
- Histone Deacetylase-3/CAGE Axis Targets EGFR Signaling and Regulates the Response to Anti-Cancer Drugs vol.39, pp.3, 2016, https://doi.org/10.14348/molcells.2016.2244
- Expression of Twist2 is controlled by T-cell receptor signaling and determines the survival and death of thymocytes vol.23, pp.11, 2016, https://doi.org/10.1038/cdd.2016.68
- Dual PI3K/mTOR inhibitor BEZ235 as a promising therapeutic strategy against paclitaxel-resistant gastric cancer via targeting PI3K/Akt/mTOR pathway vol.9, pp.2, 2018, https://doi.org/10.1038/s41419-017-0132-2
- Role of HDAC3-miRNA-CAGE Network in Anti-Cancer Drug-Resistance vol.20, pp.1, 2015, https://doi.org/10.3390/ijms20010051
- Histone Deacetylase Inhibitors to Overcome Resistance to Targeted and Immuno Therapy in Metastatic Melanoma vol.8, pp.None, 2015, https://doi.org/10.3389/fcell.2020.00486
- Epigenetic Regulation of Multidrug Resistance Protein 1 and Breast Cancer Resistance Protein Transporters by Histone Deacetylase Inhibition vol.48, pp.6, 2015, https://doi.org/10.1124/dmd.119.089953